0.849 ± 0.467 μg/L, P = 0.030, Fig. 1C), whereas obese subjects with NAFLD showed a marginal increase in betatrophin levels (1.367 ± 0.579 vs. The gene discussed is ANGPTL8; the disease is metabolic dysfunction-associated steatotic liver disease.